We used observational and Mendelian randomization analyses to test our hypothesis that plasma adiponectin is associated observationally and causally, genetically with the risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction. Here, ADIPOQ is linked to atrial fibrillation.